Chromosomal instability (CIN), the persistent reshuffling of chromosomes during mitosis, is a hallmark of human cancers that contributes to tumor heterogeneity and has been implicated in driving metastasis and altering responses to therapy. Though multiple mechanisms can produce CIN, lagging chromosomes generated from abnormal merotelic attachments are the major cause of CIN in a variety of cell lines, and are expected to predominate in cancer. Here, we quantify CIN in breast cancer using a tumor microarray, matched primary and metastatic samples, and patient-derived organoids from primary breast cancer. Surprisingly, misaligned chromosomes are more common than lagging chromosomes and represent a major source of CIN in primary and metastatic tumors. This feature of breast cancers is conserved in a majority of breast cancer cell lines. Importantly, though a portion of misaligned chromosomes align before anaphase onset, the fraction that remain represents the largest source of CIN in these cells. Metastatic breast cancers exhibit higher rates of CIN than matched primary cancers, primarily due to increases in misaligned chromosomes. Whether CIN causes immune activation or evasion is controversial. We find that misaligned chromosomes result in immune-activating micronuclei substantially less frequently than lagging and bridge chromosomes and that breast cancers with greater frequencies of lagging chromosomes and chromosome bridges recruit more stromal tumor-infiltrating lymphocytes (sTILs). These data indicate misaligned chromosomes represent a major mechanism of CIN in breast cancer and provide support for differential immunostimulatory effects of specific types of CIN.
<p>Figure S3. Lagging chromosomes in breast cancer are primarily mitotic in origin. A-B.
Images of lagging chromosomes lacking a centromere, which are likely to occur due to premitotic
defects (A) or containing their centromere, which are likely to arise due to mitotic defects
(B). C. Quantification of lagging chromosomes in 8 primary tumors showing acentric (ACA-)
fragments are less frequent than lagging chromosomes containing centromeres. Data represent
mean +/- SD.</p>
<div><p>Chromosomal instability (CIN), the persistent reshuffling of chromosomes during mitosis, is a hallmark of human cancers that contributes to tumor heterogeneity and has been implicated in driving metastasis and altering responses to therapy. Though multiple mechanisms can produce CIN, lagging chromosomes generated from abnormal merotelic attachments are the major cause of CIN in a variety of cell lines, and are expected to predominate in cancer. Here, we quantify CIN in breast cancer using a tumor microarray, matched primary and metastatic samples, and patient-derived organoids from primary breast cancer. Surprisingly, misaligned chromosomes are more common than lagging chromosomes and represent a major source of CIN in primary and metastatic tumors. This feature of breast cancers is conserved in a majority of breast cancer cell lines. Importantly, though a portion of misaligned chromosomes align before anaphase onset, the fraction that remain represents the largest source of CIN in these cells. Metastatic breast cancers exhibit higher rates of CIN than matched primary cancers, primarily due to increases in misaligned chromosomes. Whether CIN causes immune activation or evasion is controversial. We find that misaligned chromosomes result in immune-activating micronuclei substantially less frequently than lagging and bridge chromosomes and that breast cancers with greater frequencies of lagging chromosomes and chromosome bridges recruit more stromal tumor-infiltrating lymphocytes. These data indicate misaligned chromosomes represent a major mechanism of CIN in breast cancer and provide support for differential immunostimulatory effects of specific types of CIN.</p>Significance:<p>We surveyed the single-cell landscape of mitotic defects that generate CIN in primary and metastatic breast cancer and relevant models. Misaligned chromosomes predominate, and are less immunostimulatory than other chromosome segregation errors.</p></div>
<p>Figure S5. Chromosomes that are misaligned at anaphase onset are rapidly incorporated
into the main DNA masses during anaphase A. A-B. Timelapse analysis of T47D (A) and
Cal51 (B) breast cancer cells with endogenously labeled histone H2B and a-tubulin showing the
fate of misaligned chromosomes after anaphase entry. In cells that entered anaphase with
misaligned chromosomes, the majority of the misaligned chromosomes reincorporated into the
main masses of segregating DNA during anaphase A (left columns). A smaller portion of
misaligned chromosomes remained distinct from the segregating DNA masses and therefore
visible throughout anaphase A (middle column). A small minority of misaligned chromosomes
were detectable for at least 2 minutes during anaphase B (right column). n>25 cells with
misaligned chromosomes in 3 biological replicates. C-D timing of anaphase and telophase in
T47D (C) and Cal51 (D) cells. n>55 cells in 3 biological replicates.</p>
<p>Figure S4. Misaligned chromosomes are the predominant mitotic error in breast cancer
organoids. A. Biopsies of primary breast cancer were grown in Matrigel suspension into
patient-derived organoids (PDOs), which were prepared for immunofluorescence and confocal
imaging. B. Representative images of mitotic cells with misaligned chromosomes observed in
PDOs. C. Frequency of mitotic defects assessed in PDOs from 10 patients. P values derived
from unpaired t-test.</p>
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.